...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.
【24h】

Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.

机译:在免疫缺陷小鼠中移植人急性髓性白血病(AML)细胞显示出改变的细胞表面表型和人内皮标记物的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To better characterize acute myeloid leukemia (AML) development in non-obese diabetic (NOD)/severe combined immunodeficiency (SCID) mice, we transplanted samples from patients with AML or KG-1 and EOL-1 cell lines. We found 9/12 primary AML samples and both cell lines to engraft within 2-8 weeks, with 5-80% human cells in bone marrow. Compared with freshly isolated AML cells, percentages of human CD33+, CD38+, CD31+ CD13+ or CD15+ subpopulations increased after transplantation, whereas percentages of CD34+ cells decreased. Engrafted mice frequently showed expression of human endothelial cell markers. Thus, transplantation of human AML into NOD/SCID mice reveals expression of hematopoietic and endothelial differentiation markers.
机译:为了更好地表征非肥胖糖尿病(NOD)/重度联合免疫缺陷(SCID)小鼠的急性髓细胞白血病(AML)的发展,我们移植了AML或KG-1和EOL-1细胞系患者的样品。我们发现9/12原发性AML样本和两种细胞系都将在2-8周内移植,骨髓中有5-80%的人类细胞。与新鲜分离的AML细胞相比,人CD33 +,CD38 +,CD31 + CD13 +或CD15 +亚群的百分比在移植后增加,而CD34 +细胞的百分比下降。植入的小鼠经常显示出人内皮细胞标记物的表达。因此,将人AML移植到NOD / SCID小鼠中可揭示造血和内皮分化标志物的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号